Adcetris 50mg Injection (Brentuximab Vedotin) – Imported

Adcetris 50mg Injection contains Brentuximab Vedotin, a CD30-directed antibody-drug conjugate used in the treatment of certain CD30-positive lymphomas. It is supplied as a 50mg powder for concentrate for solution for infusion and is administered intravenously by qualified healthcare professionals.

Uses of Adcetris 50mg Injection

Adcetris may be used as part of treatment for specific types of lymphoma, including classical Hodgkin lymphoma (cHL) and certain T-cell lymphomas. Depending on the indication, it may be used alone or in combination with other anticancer medicines. Current approved indications include certain previously untreated or relapsed/refractory forms of Hodgkin lymphoma, systemic anaplastic large cell lymphoma, CD30-expressing peripheral T-cell lymphomas, and selected cutaneous T-cell lymphomas.

How Adcetris Works

Brentuximab Vedotin is designed to target cells expressing CD30. The antibody component binds to CD30 on the target cell and delivers the antimicrotubule agent monomethyl auristatin E (MMAE) into the cell, helping inhibit cell division and promote cell death.

Administration and Dosage

Adcetris 50mg Injection is given by intravenous infusion under the supervision of a physician experienced in using anticancer medicines. The recommended dose varies according to the type of lymphoma, treatment regimen, age, body weight, and individual patient factors. For example, specific Hodgkin lymphoma regimens use weight-based dosing rather than simply administering an entire 50mg vial.

The medicine should be reconstituted and diluted according to the approved product instructions and should not be self-administered.

Important Safety Information

Adcetris carries important warnings and precautions. Serious adverse reactions can occur, including progressive multifocal leukoencephalopathy (PML), a rare but potentially fatal infection associated with JC virus. Patients should also be monitored for peripheral neuropathy, infusion-related reactions, infections, neutropenia, and other treatment-related complications.

Common Side Effects

Possible side effects may include:

• Peripheral neuropathy
• Nausea and vomiting
• Fatigue
• Fever
• Diarrhea or constipation
• Upper respiratory tract infections
• Neutropenia and other blood-cell abnormalities
• Rash
• Headache
• Infusion-related reactions

The actual risk depends on the treatment regimen and the patient’s medical condition.

Precautions

Before treatment with Adcetris, patients should inform their healthcare provider about all medicines they are taking and any existing liver, kidney, or neurological problems. Certain medicines can interact with Brentuximab Vedotin, including strong CYP3A4 inhibitors or inducers. Adcetris should be used only according to the prescribing oncologist’s instructions.

Adcetris is intended for intravenous use only and must be administered by trained healthcare professionals.

Pregnancy and Breastfeeding

Brentuximab Vedotin may cause fetal harm. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks with their healthcare provider before treatment. Current prescribing information advises avoiding breastfeeding during treatment.

Storage

The unopened Adcetris vial should generally be stored at 2°C to 8°C in its original carton and protected from light. Follow the product-specific storage and handling instructions supplied with the medicine.

Product Information

• Product Name: Adcetris 50mg Injection
• Active Ingredient: Brentuximab Vedotin
• Strength: 50mg
• Dosage Form: Powder for concentrate for solution for infusion
• Route: Intravenous infusion
• Pack Size: 1 vial
• Manufacturer/Brand: Adcetris
• Origin: Imported

Why Choose Adcetris 50mg Injection?

Adcetris contains Brentuximab Vedotin, a targeted CD30-directed therapy used in several approved lymphoma treatment settings. Its antibody-drug conjugate mechanism allows targeted delivery of an antimicrotubule agent to CD30-expressing cells.

For authentic and properly handled imported medicines, patients should purchase through a reputable pharmaceutical supplier and use Adcetris only under the supervision of their treating specialist.

Frequently Asked Questions

What is Adcetris 50mg Injection used for?

Adcetris is used for certain CD30-positive lymphomas, including specified forms of classical Hodgkin lymphoma and T-cell lymphomas.

What is the generic name of Adcetris?

The active ingredient in Adcetris is Brentuximab Vedotin.

How is Adcetris administered?

It is administered by intravenous infusion by a qualified healthcare professional.

Can Adcetris be self-administered?

No. Adcetris is an intravenous anticancer medicine that requires preparation and administration by trained healthcare professionals.

Does Adcetris require refrigeration?

Yes. The unopened vial is generally stored at 2°C to 8°C and protected from light.

Is Adcetris a chemotherapy medicine?

Adcetris is an antibody-drug conjugate (ADC). It combines a CD30-directed monoclonal antibody with the antimicrotubule agent MMAE and may be used alone or with chemotherapy depending on the indication.